Among the 861 breast cancer patients included in the present study, 223 patients were classified as luminal A subtype (25.9%), 407 patients were Luminal B subtype (47.3%), 135 patients were HER2 subtype (15.7%), and 96 patients were TNBC subtype (11.1%). Here, ERBB2 is linked to breast carcinoma.